FBInvestor
Stocks / Proqr Thrapeutics N V
Institutional Ownership

Proqr Thrapeutics N V

CUSIP N71542109SHS EUROQ1 2026

Institutional Holders
69
13F filers
Shares Held
35.09M
Aggregate institutional
Institutional Value
$56.65M
Q1 2026
Net New Holders
+4
9 new · 5 closed

Institutional Ownership Trend

Aggregate 13F value by quarter

Multi-quarter trend — upgrade to see history

Upgrade

Position Activity

Q1 2026

New positions9
Increased14
Decreased16
Sold out5

Institutional Holders

69 funds hold this security · Q1 2026

#FundSharesValueΔ SharesActivity
1Adage Capital Partners Gp, L.L.C.6.25M$10.13M0Held
2Privium Fund Management B.V.5.47M$8.86M+109.4KAdded
3Aberdeen Group PLC3.32M$5.37M+366.3KAdded
4Affinity Asset Advisors, LLC2.45M$3.98M0Held
5Sio Capital Management, LLC1.95M$3.17M209.5KReduced
6Dafna Capital Management LLC1.57M$2.54M0Held
7Kynam Capital Management, LP1.57M$2.54M0Held
8Ikarian Capital, LLC1.49M$2.42M0Held
9Morgan Stanley1.30M$2.11M67.3KReduced
10Platinum Investment Management Ltd1.24M$2.00M0Held

59 more institutional holders on Premium

See every fund holding Proqr Thrapeutics N V, with full quarter-over-quarter share changes.

Unlock all holders